pentobarbital will minimize the level or impact of exemestane by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. For clients acquiring exemestane with a strong CYP3A4 inducer the encouraged dose of exemestane is 50 mg day-to-day following a food.pentobarbital will decrease the level or effect of buprenorphine subdermal i